https://pubmed.ncbi.nlm.nih.gov/31827283/
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
Adoptive cell therapy represents a new paradigm in cancer immunotherapy, but it can be limited by the poor persistence and function of transferred T...
long lived